Key result
Each percentage point increase in mean HbA1c was associated with a 31% increased risk for any-CVD and a 42% increased risk for major cardiovascular events in patients with type 1 diabetes.
Why the study?
What are the risk factors for cardiovascular disease in patients with type 1 diabetes?
Cohort
What are the risk factors for cardiovascular disease in patients with type 1 diabetes?
In patients with type 1 diabetes, hyperglycemia (HbA1c) is a major risk factor for cardiovascular disease, second only to age.
Answers are grounded in this paper and cite their sources.
Reinforces HbA1c monitoring for CVD risk in type 1 diabetes; extends observational data but remains hypothesis-generating.
Risk factors for cardiovascular disease (CVD) are well-established in type 2 but not type 1 diabetes (T1DM). We assessed risk factors in the long-term (mean 27 years) follow-up of the Diabetes Control and Complications Trial (DCCT) cohort with T1DM. Cox proportional hazards multivariate models assessed the association of traditional and novel risk factors, including HbA1c, with major atherosclerotic cardiovascular events (MACE) (fatal or nonfatal myocardial infarction [MI] or stroke) and any-CVD (MACE plus confirmed angina, silent MI, revascularization, or congestive heart failure). Age and mean HbA1c were strongly associated with any-CVD and with MACE. For each percentage point increase in mean HbA1c, the risk for any-CVD and for MACE increased by 31 and 42%, respectively. CVD and MACE were associated with seven other conventional factors, such as blood pressure, lipids, and lack of ACE inhibitor use, but not with sex. The areas under the receiver operating characteristics curves for the association of age and HbA1c, taken together with any-CVD and for MACE, were 0.70 and 0.77, respectively, and for the final models, including all significant risk factors, were 0.75 and 0.82. Although many conventional CVD risk factors apply in T1DM, hyperglycemia is an important risk factor second only to age.
No takes yet. Share an insight, caveat, or question.
A 2016 study conducted a cohort in Type 1 diabetes. Mean HbA1c was evaluated on Major atherosclerotic cardiovascular events (MACE) and any-CVD (31% increase for any-CVD, 42% increase for MACE per 1% increase in HbA1c). Each percentage point increase in mean HbA1c was associated with a 31% increased risk for any-CVD and a 42% increased risk for major cardiovascular events in patients with type 1 diabetes.
Synapse has enriched 10 related papers. Consider them for comparative context: